Nicolino Paula Silva, Vedana Kelly Graziani Giacchero, Miasso Adriana Inocenti, Cardoso Lucilene, Galera Sueli Aparecida Frari
Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil.
Rev Esc Enferm USP. 2011 Jun;45(3):708-15. doi: 10.1590/s0080-62342011000300023.
This study verified the adherence of people with schizophrenia to the medication, identified and compared their beliefs about the disorder and the drug among patients who adhered and those who did not. Participants were 14 patients of a psychiatric outpatient clinic. Semi-structured interviews and the Morisky-Green test were performed. The data was analyzed using a quali-quantitative approach. Results showed that 64.3% of patients do not adhere to treatment. Most participants considered the drug capable of reducing the seriousness and severity of the disorder. However, the drawbacks for patients that did not adhere to the treatment were more expressive. Side effects were the cause for interrupting the treatment for 80% of patients who intentionally did not adhere to treatment. It was observed there is insufficient knowledge about schizophrenia and the drug treatment. Patients referred to faith as a strategy to cope with the process they were experiencing. This study points at the need for strategies directed towards the promotion of drug treatment adherence among people with schizophrenia.
本研究验证了精神分裂症患者的药物依从性,在依从和不依从的患者中识别并比较了他们对该疾病和药物的看法。研究对象为一家精神科门诊诊所的14名患者。进行了半结构化访谈和莫里西-格林测试。采用定性-定量方法对数据进行分析。结果显示,64.3%的患者不坚持治疗。大多数参与者认为药物能够减轻疾病的严重程度。然而,不坚持治疗的患者所面临的不利因素更为明显。副作用是80%故意不坚持治疗的患者中断治疗的原因。研究发现,患者对精神分裂症和药物治疗的了解不足。患者提到将信仰作为应对自身经历过程的一种策略。本研究指出需要制定策略来提高精神分裂症患者的药物治疗依从性。